Provided by Tiger Trade Technology Pte. Ltd.

ORUKA THERAPEUTICS INC

89.09
-2.0550-2.25%
Volume:28.02K
Turnover:2.52M
Market Cap:5.90B
PE:-44.01
High:91.08
Open:91.00
Low:88.32
Close:91.15
52wk High:115.52
52wk Low:14.67
Shares:66.21M
Float Shares:56.65M
Volume Ratio:1.04
T/O Rate:0.05%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.0242
EPS(LYR):-1.8483
ROE:-18.23%
ROA:-12.95%
PB:5.31
PE(LYR):-48.20

Loading ...

Aug 24, 2026

Major Issues Report

Form 8-K - Current report
Aug 14, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 14, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Aug 14, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Aug 14, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Aug 12, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Aug 10, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 10, 2026

Major Issues Report

Form 8-K - Current report
Jul 15, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 13, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 01, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 12, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 05, 2026

Major Issues Report

Form 8-K - Current report
Jun 01, 2026

Major Issues Report

Form 8-K - Current report
May 21, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 18, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 15, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
May 13, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 01, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 30, 2026

Major Issues Report

Form 8-K - Current report